biote Corp. (BTMD) Stock

Healthcare · Medical Care Facilities · Member of Other US Stocks

biote Corp. (BTMD) closed at USD 1.13 on 2026-10-14, a change of -58.8 % over the past year, with a market capitalization of USD 37.63M.

biote Corp. recent closing prices

DateClose (USD)
2026-10-141.13
2026-10-131.04
2026-10-121.14
2026-10-091.15
2026-10-081.17
2026-10-071.11
2026-10-061.14

The most recent trading day is not shown. For full charts and indicators use the analysis page.

biote Corp. key figures

Previous close
USD 1.13 (2026-10-14)
1-year change
-58.8 %
Market cap
USD 37.63M
Enterprise value
USD 156.9M
P/E ratio (trailing)
7.93
P/E ratio (forward)
2.47
EPS (trailing)
0.14
EPS (forward)
0.45
PEG ratio
n/a
Price to book
-0.47
Revenue growth
-9.5 %
Earnings growth
n/a
Dividend per share (trailing)
0.00
Short ratio
6.02
Employees
223
Analyst consensus (third-party)
none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About biote Corp.

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for biote Corp. and compare it with other stocks.

Analyze BTMDAll Other US Stocks stocks

Stock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell biote Corp. shares.